BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12895604)

  • 1. Effects of preoperative chemoradiotherapy on postsurgical morbidity and mortality in cT3-4 +/- cM1lymph cancer of the oesophagus and gastro-oesophageal junction.
    Hagry O; Coosemans W; De Leyn P; Nafteux P; Van Raemdonck D; Van Cutsem E; Hausterman K; Lerut T
    Eur J Cardiothorac Surg; 2003 Aug; 24(2):179-86; discussion 186. PubMed ID: 12895604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction therapy for clinical T4 oesophageal carcinoma; a plea for continued surgical exploration.
    Van Raemdonck D; Van Cutsem E; Menten J; Ectors N; Coosemans W; De Leyn P; Lerut T
    Eur J Cardiothorac Surg; 1997 May; 11(5):828-37. PubMed ID: 9196296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term survival after curative resection for oesophageal and cardia cancer].
    Kofoed SC; Brandt B; Brenø J; Bardram L; Gustafsen J; Holm J; Jendresen M; Svendsen LB
    Ugeskr Laeger; 2010 May; 172(21):1597-602. PubMed ID: 20525472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
    Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
    Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
    Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
    Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for cancers of the oesophagus, cardia and stomach.
    Créhange G; Modesto A; Vendrely V; Quéro L; Mirabel X; Rétif P; Huguet F
    Cancer Radiother; 2022; 26(1-2):250-258. PubMed ID: 34955417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic significance of the Mandard TRG classification after induction therapy in carcinoma of the oesophagus and cardia].
    Zanoni A; Verlatoa G; Minicozzi A; Tomezzoli A; Giacopuzzi S; Di Cosmo M; Franceschetti I; Saladino E; De Manzoni G
    Chir Ital; 2009; 61(4):419-25. PubMed ID: 19845263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-operative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction.
    Stahl M; Vanhoefer U; Stuschke M; Walz MK; Müller C; Wilke H
    Eur J Cancer; 1998 Apr; 34(5):668-73. PubMed ID: 9713272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
    El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
    World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 101 oesophageal cancers: a surgeon uses radiotherapy.
    Earlam RJ; Johnson L
    Ann R Coll Surg Engl; 1990 Jan; 72(1):32-40. PubMed ID: 1689132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Jestin Hannan C; Linder G; Kung CH; Johansson J; Lindblad M; Hedberg J
    Br J Surg; 2020 Oct; 107(11):1500-1509. PubMed ID: 32484241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic Features are more Important Prognostic Factors than Primary Tumour Location in Gastro-oesophageal Adenocarcinoma Treated with Preoperative Chemoradiation and Surgery.
    Vošmik M; Laco J; Sirák I; Dvořák J; Lochman P; Hodek M; Malá P; Rejchrt S; Repák R; Leško M; Ferko A; Ryška A; Melichar B; Petera J
    Pathol Oncol Res; 2018 Apr; 24(2):373-383. PubMed ID: 28550507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry.
    Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M
    Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphadenectomy with tumors of the upper gastrointestinal tract].
    Schuhmacher C; Novotny A; Ott K; Feith M; Siewert JR
    Chirurg; 2007 Mar; 78(3):203-6, 208-12, 214-6. PubMed ID: 17333037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy comparison between two-field and three-field lymphadenectomy for thoracic esophageal squamous cell carcinoma].
    Lin D; Ye T; Ma L; Shao L; Song Z; Jiang S; Xiang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):990-994. PubMed ID: 27680065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
    Watkins JM; Zauls AJ; Kearney PL; Shirai K; Ruppert BN; Harper JL; Sherman CA; Aguero EG; Reed CE; Sharma AK
    Jpn J Clin Oncol; 2011 Mar; 41(3):334-42. PubMed ID: 21084436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced adenocarcinomas of the gastric cardia: results of pre-operative chemoradiotherapy.
    Balandraud P; Moutardier V; Giovannini M; Giovannini MH; Lelong B; Guiramand J; Magnin V; Houvenaeghel G; Delpero JR
    Gastroenterol Clin Biol; 2004; 28(8-9):651-7. PubMed ID: 15646531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.